E.g., 07/01/2022
E.g., 07/01/2022

Cannabis and Hemp are Safer for Consumers with New Microbial Testing Method Validations

26 January, 2021

bioMérieux receives the first AOAC® validation approval for cannabis and hemp.

Holiday Shipping Schedule

12 January, 2021

Please be advised that bioMérieux Inc. sites in Durham, NC, St. Louis, MO, and Lombard, IL will be closed on Monday, January 18th, 2021 in observance of the upcoming holiday.

bioMérieux Awarded First-ever COVID-19-Related AOAC Emergency Response Validation for its VERIPRO® SARS-CoV-2 Environmental Assay

18 December, 2020

The Assay couples the advantages of real-time PCR technology with a streamlined environmental sampling protocol, providing rapid and accurate results with superior specificity.

bioMérieux, Inc. Receives Nine AOAC Approvals in November

07 December, 2020

These approvals add to bioMérieux’s already vast AOAC approved portfolio across their pathogen and quality indicator suite of solutions, and demonstrates a long-standing commitment to robust, sound, and validated science.

bioMérieux Announces CLARION™ Infectious Diseases and Diagnostics Software

19 November, 2020

The innovative software-as-a-service reflects growing capabilities and global mission for antimicrobial stewardship and surveillance.

Holiday Shipping Schedule

17 November, 2020

Please be advised that in observance of upcoming holidays, bioMérieux, Inc. sites in Durham, NC, St. Louis, MO, Louisville, KY, and Lombard, IL will be closed on: Thursday/Friday November 26/27, 2020 Thursday/Friday December 24/25, 2020 Friday January 1, 2021 We encourage you to place orders with the following dates in mind.

bioMérieux launches Predictive Diagnostics, pairing microbiology solutions with data science, sequencing and predictive modeling

26 October, 2020

Predictive Diagnostics uses traditional core microbiology solutions alongside data science, sequencing applications and predictive modeling to help move food producers from being reactive to being proactive.

10 Organizations Across U.S. Receive Over €3 Million From bioMérieux

12 October, 2020

Due to the significant economic and social consequences presented by the COVID-19 pandemic, bioMérieux has decided to distribute 50% of its 2019 dividend as corporate philanthropy to support charitable initiatives around the world.

Mérieux NutriSciences EnviroMap Collaborates with bioMérieux, Inc.

04 September, 2020

Mérieux NutriSciences collaborates with bioMérieux, Inc. to deliver EnviroMap® to the food industry.

bioMérieux Receives Emergency Use Authorization for Its VIDAS® SARS-CoV-2 Antibody Serology Tests

07 August, 2020

bioMérieux has received Emergency Use Authorization by the U.S. Food and Drug Administration of its VIDAS® SARS-COV-2 IgM and VIDAS® SARS-COV-2 IgG serology tests.

Pioneering Diagnostics